CD44 and cancer: The MCs also expressed high levels of the Homing-associated cell adhesion molecule (H-CAM/CD44) and released CD44+ EVs which reprogrammed the secretory profile of cancer cells by activating the β-catenin signaling pathway, causing upregulation of genes related to EMT and increasing cancer cell invasiveness.